Related Experiment Video
Updated: Mar 27, 2026
10:03
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
944
[Clinical Value of Left Ventricular Hypertrophy in Arterial Hypertension]
Kardiologiia
|January 15, 2016
Insights
Left ventricular hypertrophy is common in arterial hypertension patients. This review covers its prevalence, predictors, detection methods, and diagnostic criteria for better patient management.
Area of Science:
- Cardiology
- Hypertension Research
- Clinical Diagnostics
Context:
- Arterial hypertension is a widespread condition associated with significant cardiovascular risks.
- Left ventricular hypertrophy (LVH) is a key cardiac adaptation in hypertension, impacting prognosis.
- Understanding LVH prevalence and predictors is crucial for effective hypertension management.
Purpose:
- To review the current data on the prevalence of left ventricular hypertrophy (LVH) in patients with arterial hypertension.
- To identify and discuss the key predictors associated with the development of LVH.
- To outline the established methods for detecting LVH and the relevant diagnostic criteria.
Summary:
- This review synthesizes data on the prevalence of left ventricular hypertrophy (LVH) in individuals with arterial hypertension.
- It examines established predictors for LVH development and discusses current detection methodologies.
- Diagnostic criteria for LVH in hypertensive patients are presented and analyzed.
Impact:
- Provides a comprehensive overview for clinicians managing hypertensive patients.
- Aids in the early identification and diagnosis of left ventricular hypertrophy.
- Contributes to improved risk stratification and treatment strategies for arterial hypertension.
Abstract:
In this review article we present data on prevalence of left ventricular hypertrophy in patients with arterial hypertension, on predictors of its development, methods of detection, and diagnostic criteria.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
687
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
687
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
863
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
863
01:29Heart Failure II: Pathophysiology
1.4K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
01:20Mitral Regurgitation I: Introduction
989
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
989
01:25Aortic Regurgitation III: Medical Management
548
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
548
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
711
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
711